Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients

作者：Chaher Nabila; Arias Pulido Hugo^*; Terki Nadija; Qualls Clifford; Bouzid Kamel; Verschraegen Claire; Wallace Anne Marie; Royce Melanie

来源：Breast Cancer Research and Treatment, 2012, 131(2): 437-444.

DOI：10.1007/s10549-011-1422-5

• Inflammatory breast cancer
• Locally advanced breast cancer
• Tumor emboli
• Tumor subtypes
• Hormone receptors
• Growth factor receptors
• Overall survival
• Disease-free survival

Inflammatory breast cancer (IBC) shows a high incidence in Tunisia and Egypt but epidemiological and molecular characteristics have not been described in Algeria. We compared 117 IBC and 59 non-IBC locally advanced breast cancers (LABC), for estrogen and progesterone receptors, HER2, and EGFR protein expression by immunohistochemistry, and HER2 gene amplification by chromogenic in situ hybridization. Demographic, clinico-pathological, and molecular variables were compared with chi-square and Fisher%26apos;s exact tests to test for significance (P %26lt; 0.05, two-tailed). Overall survival (OS) and disease-free survival (DFS) were plotted using Kaplan-Meier curves and compared using the log-rank test. Tumor emboli were detected in 77% of IBC. Palpable masses were found in all LABC but only in 32% of IBC (P %26lt; 0.001). Recurrences were higher in LABC than in IBC (48 vs. 35%; P = 0.14) but OS was worse in IBC (68 vs. 71%; P = 0.06). There were no significant differences between IBC and LABC by demographics or by clinico-pathological parameters. The majority of IBC and LABC tumors were luminal A (62 and 64%), followed by basal (similar to 18%, each), triple negative (similar to 18%, each), and HER2+ (similar to 10%, each) subtypes. In multivariate analyses, grade was associated with worse OS (P = 0.04), and DFS (P %26lt; 0.001) in IBC; chemo- and radio-therapy were associated with improved OS and DFS, respectively (P %26lt; 0.05 for each) in LABC. In conclusion, IBC in Algeria shows similar characteristics to IBC described for Egypt and Tunisia with subtle molecular differences. Current therapeutic treatments were not very effective in this population and new approaches are much needed.

• 出版日期2012-1